VMC
60
3
UHS
54
-8
MKC
42
-2
SBUX
35
2
LOW
39
-3
NTRS
45
6
EW
40
-4
PNR
56
2
TRIP
52
3
XEL
50
-3
NAVI
41
6
EQIX
50
2
HIG
70
-2
CME
37
3
CB
50
-4
PGR
65
-5
MDLZ
36
-4
EXR
53
2
LRCX
77
2
BF.B
51
-2
VMC
60
3
UHS
54
-8
MKC
42
-2
SBUX
35
2
LOW
39
-3
NTRS
45
6
EW
40
-4
PNR
56
2
TRIP
52
3
XEL
50
-3
NAVI
41
6
EQIX
50
2
HIG
70
-2
CME
37
3
CB
50
-4
PGR
65
-5
MDLZ
36
-4
EXR
53
2
LRCX
77
2
BF.B
51
-2
Financhill
Back

ProShares UltraShort Energy Vs. Keros Therapeutics Industry Stock Comparison

Sell
36

DUG
ProShares UltraShort Energy

Last Price:
9.55
Seasonality Move:
0.03%
Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
-4.71%
Sell
36
ProShares UltraShort Energy (DUG) is a Sell

Is ProShares UltraShort Energy a Buy, Sell or Hold?

  • The current ProShares UltraShort Energy [DUG] share price is $9.51. The Score for DUG is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • DUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DUG Stock Price Chart

What is ProShares UltraShort Energy's stock price today?

  • The ProShares UltraShort Energy share price today is $9.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DUG is experiencing slight buying pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

DUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 41.41 Sell
Chaikin Money Flow: 15301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.67 - 10.31) Sell
Bollinger Bands (100): (8.98 - 10.78) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

DUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.86 Sell
20-day SMA: 10.03 Sell
50-day SMA: 9.61 Sell
200-day SMA: 10.67 Sell
8-day EMA: 9.79 Sell
20-day EMA: 9.89 Sell
50-day EMA: 9.8 Sell
200-day EMA: 10.77 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

ProShares UltraShort Energy Earnings Growth & DUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

ProShares UltraShort Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):